Drug-drug interactions: how scared should we be?
暂无分享,去创建一个
[1] R. Herman,et al. Drug interactions and the statins. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[2] M. B. Bottorf. Distinct drug-interaction profiles for statins. , 1999, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[3] R. Kauffman,et al. Investigation of terbinafine as a CYP2D6 inhibitor in vivo , 1999, Clinical pharmacology and therapeutics.
[4] R. Rosenson,et al. Long‐Term safety of pravastatin‐gemfibrozil therapy in mixed hyperlipidemia , 1999, Clinical cardiology.
[5] Drug interactions: Who warns the patient. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[6] R. Hamilton,et al. Frequency of Hospitalization after Exposure to Known Drug‐Drug Interactions in a Medicaid Population , 1998, Pharmacotherapy.
[7] D. Sonnichsen,et al. Clinically Significant Cytochrome P‐450 Drug Interactions—A Comment , 1998, Pharmacotherapy.
[8] I. Bernstein,et al. Predictors of potential drug interactions , 1998 .
[9] Elizabeth Landrum Michalets,et al. Update: Clinically Significant Cytochrome P‐450 Drug Interactions , 1998, Pharmacotherapy.
[10] J. Chan,et al. Medication misadventures resulting in emergency department visits at and HMO medical center. , 1996, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[11] C. A. Jankel,et al. Epidemiology of Drug-Drug Interactions as a Cause of Hospital Admissions , 1993, Drug safety.
[12] C. L. Ferguson,et al. Torsades de pointes occurring in association with terfenadine use. , 1990, JAMA.
[13] V. Aboyans,et al. [Drug interactions]. , 2015, Journal of the Dental School, National University of Iran.